Global Myopia and Presbyopia Treatment Market Table of Contents 1. INTRODUCTION 2. ASSUMPTIONS AND ACRONYMS 3. RESEARCH METHODOLOGY 4. EXECUTIVE SUMMARY - GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET 5. ANALYSIS OF MARKET DYNAMICS 5.1. DRIVERS 5.2. RESTRAINTS 5.3. TRENDS 6. KEY MARKET OPPORTUNITIES 7. INDUSTRY RISK ANALYSIS 7.1. DEMAND RISK ANALYSIS 7.2. SUPPLY RISK ANALYSIS 8. REGULATORY LANDSCAPE 9. IMPACT OF COVID-19 ON MYOPIA & PRESBYOPIA TREATMENT 10. MYOPIA & PRESBYOPIA TREATMENT MARKET OUTLOOK 10.1. MARKET SIZE AND FORECAST, 2018-2028 10.1.1. BY VALUE (USD MILLION) 10.2. MYOPIA & PRESBYOPIA TREATMENT MARKET SEGMENTATION, 2018-2028 10.2.1. BY REGIONS v NORTH AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET, 2018-2028F (USD MILLION) § MARKET SIZE, 2018-2028F (USD MILLION) § MARKET ANALYSIS § BY COUNTRY o ASSESSMENT OF MACROECONOMIC FACTORS o US & CANADA, 2018-2028F (USD MILLION) v EUROPE MYOPIA & PRESBYOPIA TREATMENT MARKET, 2018-2028F (USD MILLION) § MARKET SIZE, 2018-2028F (USD MILLION) § MARKET ANALYSIS § BY COUNTRY o ASSESSMENT OF MACROECONOMIC FACTORS o UK & GERMANY, 2018-2028F (USD MILLION) o FRANCE & ITALY, 2018-2028F (USD MILLION) o SPAIN & RUSSIA, 2018-2028F (USD MILLION) o REST OF EUROPE, 2018-2028F (USD MILLION) v ASIA PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET, 2018-2028F (USD MILLION) § MARKET SIZE, 2018-2028F (USD MILLION) § MARKET ANALYSIS § BY COUNTRY o ASSESSMENT OF MACROECONOMIC FACTORS • CHINA & INDIA, 2018-2028F (USD MILLION) • o JAPAN & SOUTH KOREA, 2018-2028F (USD MILLION) • o AUSTRALIA & MALAYSIA, 2018-2028F (USD MILLION) • o REST OF ASIA PACIFIC, 2018-2028F (USD MILLION) • LATIN AMERICA MYOPIA & PRESBYOPIA TREATMENT MARKET, 2018-2028F (USD MILLION) • MARKET SIZE, 2018-2028F (USD MILLION) • MARKET ANALYSIS • BY COUNTRY • o ASSESSMENT OF MACROECONOMIC FACTORS • o BRAZIL & MEXICO, 2018-2028F (USD MILLION) • o REST OF LATIN AMERICA, 2018-2028F (USD MILLION) • MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET, 2018-2028F (USD MILLION) • MARKET SIZE, 2018-2028F (USD MILLION) • MARKET ANALYSIS • BY COUNTRY • o ASSESSMENT OF MACROECONOMIC FACTORS • o UNITED ARAB EMIRATES & SAUDI ARABIA, 2018-2028F (USD MILLION) • o ISRAEL & SOUTH AFRICA, 2018-2028F (USD MILLION) • o REST OF MIDDLE EAST & AFRICA, 2018-2028F (USD MILLION) • 11. COMPETITIVE STRUCTURE • 11.1. DETAILED OVERVIEW • 11.2. COMPETITIVE BENCHMARKING • 11.3. ASSESSMENT OF KEY PRODUCT OFFERINGS • 11.4. ANALYSIS OF GROWTH STRATEGIES • 11.5. KEY COLLABORATIONS AND JOINT VENTURES • 11.6. KEY MERGERS AND ACQUISITIONS • 11.7. RECENT NEWS AND DEVELOPMENTS • 11.8. KEY CLIENTS AND PARTNERS • 11.9. EXHAUSTIVE ANALYSIS ON KEY FINANCIAL INDICATORS • 11.10. COMPANY PROFILES • 11.10.1. TOPCON CORPORATION • 11.10.2. ALCON • 11.10.3. BAUSCH & LOMB INCORPORATED • 11.10.4. NIDEK CO., LTD. • 11.10.5. CARL ZEISS AG • 11.10.6. JOHNSON & JOHNSON VISION • 12. STRATEGIC RECOMMENDATIONS |
Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Myopia and Presbyopia Treatment Market size was over USD 20.39 billion in 2024 and is anticipated to cross USD 61.77 billion by 2037, witnessing more than 8.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of myopia and presbyopia treatment is estimated at USD 21.93 billion.
Myopia and Presbyopia Treatment Sector: Growth Drivers and Challenges
Growth Drivers
Rising prevalence of myopia and presbyopia is the major factor resulting in the demand for products that are used to treat the conditions. These are highly common ophthalmic conditions which occur among people of all ages. Treatment includes a range of equipment for surgeries such as LASIK and the use of lenses which is expected to boost the demand for the overall market over the forecast period. The usage of lenses is the most commonly used method to manage the disorder, although LASIK surgeries are also gaining significant traction across the globe primarily as a result of rising awareness towards the benefits of long-term solutions. Lenses are available in the form of eyeglasses, contact lenses or intra-ocular lenses out of which eyeglasses are presently the most commonly used product on account of lower price point and less maintenance requirement. Moreover, the growing population above the age of 65 is another significant factor predicted to boost the market growth.
Challenges
Rising healthcare costs which restrict a large section of the population from using these corrective treatment methods is estimated to be a major growth limiting factor for the market. Further, in developing countries, the access to affordable healthcare is limited which is predicted to be another barrier for the market growth over the forecast period.
Myopia and Presbyopia Treatment Market: Key Insights
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
8.9% |
Base Year Market Size (2024) |
USD 20.39 billion |
Forecast Year Market Size (2037) |
USD 61.77 billion |
Regional Scope |
|
Myopia and Presbyopia Treatment Segmentation
Our in-depth analysis of the global market includes the following segments:
Treatment Type |
|
Presbyopia Treatment Type |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportMyopia and Presbyopia Treatment Industry - Regional Synopsis
The market for myopia and presbyopia treatment is segmented on the basis of region into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
North America
North America industry is likely to hold largest revenue share of 36% by 2037. This can be primarily attributed to the growing demand for advanced eye care products across the world.
Moreover, the increase in investments towards healthcare by government and private entities in order to maintain the highest quality of care offered at healthcare facilities is another major growth driving factor in the region. The market in the United States is anticipated to observe the highest growth in the region, attaining a market value of USD 5,522.15 million in 2019. The market is estimated to rise on the back of increasing adoption of advanced ophthalmic diagnostic products resulting in timely identification of myopia & presbyopia, which is resulting in the high demand for effective treatment solutions.
Europe
The market in Europe is anticipated to reach a significantly high market size of USD 9,716.29 million by 2028. It has been observed that with the rising availability of innovative treatment methods, particularly LASIK treatment, there has been a rise in demand for effective treatment products in the region. Myopia and presbyopia treatment market is primarily driven by the demand from Germany, UK, France and Italy. On account of these factors, the market in this region is expected to showcase a high growth over the forecast period.
Asia Pacific
Myopia and presbyopia treatment market in Asia Pacific is projected to grow at the highest rate during the forecast period with a CAGR of 8.87% between 2021 and 2028. The market in China is leading in this region as a result of rising availability of advanced healthcare in this region along with rising number of manufacturers investing in the country, along with others such as Japan and India to address the growing demand for advanced vision care products in this region.
Latin America
The demand for myopia & presbyopia treatment products in the Latin America region is expected to develop gradually over the forecast period. Although various public as well as private initiatives such as free eye care camps are resulting in timely diagnostics of various ophthalmic disorders, the region is presently capturing a limited market share in the global market. The market is primarily led by the high demand in Brazil where the changing consumer behavior towards preventive health measures is anticipated to result in relatively higher adoption of various treatments of the eye.
Middle East & Africa
The Middle East & Africa region is generating a moderate demand for the myopia & presbyopia treatment products. The market in this region is witnessing limited players with narrow market penetration along with low awareness regarding the innovative healthcare practices as opposed to conventional mode of care, which is resulting in a relatively modest demand from this region. However, with gradually rising disposable income, encouraging government regulatory policies, and a potential interest of global manufacturers to have a direct market presence in this region, it is predicted that the market for myopia & presbyopia treatment in the region would grow over the forecast period.

Companies Dominating the Myopia and Presbyopia Treatment Landscape
- Topcon Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Alcon, Bausch & Lomb Incorporated,
- Nidek Co., Ltd.,
- Carl Zeiss AG
- Johnson & Johnson Vision.
Some of the affluent industry leaders in the global myopia and presbyopia treatment market are
In the News
- March, 2020: Alcon announced the launch of Vivity, which is the Presbyopia-correcting intraocular lens consisting of X-WAVE technology in the European market.
- January, 2020: Bausch + Lomb launched a daily disposable contact lenses product namely, Biotrue ONEday for astigmatism. This has helped the company to expand its lens parameter by 60%.
Author Credits: Radhika Pawar
- Report ID: 2475
- Published Date: Dec 23, 2024
- Report Format: PDF, PPT